Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ORAGENICS INC Director's Dealing 2013

Dec 20, 2013

35380_dirs_2013-12-20_2e80e169-b061-48ee-b2d7-504d8ac8fe57.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAGENICS INC (OGEN)
CIK: 0001174940
Period of Report: 2013-12-04

Reporting Person: KOSKI FAMILY LP (10% Owner)
Reporting Person: KOSKI BEVERLY (10% Owner)
Reporting Person: KOSKI CHRISTINE L (Director, 10% Owner)
Reporting Person: KOSKI ROBERT C (Director, 10% Owner)
Reporting Person: KOSKI THOMAS L (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-12-04 Common Stock G 33185 $0.00 Disposed 292878 Direct
2013-12-04 Common Stock G 33185 $0.00 Acquired 530851 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 765729 Direct
Common Stock 9163742 Direct
Common Stock 669666 Direct
Common Stock 14000 Indirect

Footnotes

F1: Represents the aggregate amount of bona fide gifts by Mr. Robert Koski to the following trusts for his children and in the share amounts indicated: the Robert Clayton Koski Trust for the benefit of Anthony James Hunter (7,600 shares); the Robert Clayton Koski Trust for the benefit of Hunter Buchanan Koski (7,600 shares); the Robert Clayton Koski Trust for the benefit of Robert Edward Koski (7,600 shares); and the Robert Clayton Koski Trust for the benefit of Elyse Margaux Koski (10,385 shares).

F2: Shares owned directly by Robert C. Koski.

F3: Shares owned directly by Christine L. Koski.

F4: Shares owned directly by Koski Family Limited Partnership. Shares owned indirectly by Beverly Koski (through Koski Management, Inc. solely owned by Beverly Koski), Christine L. Koski, Robert C. Koski and Thomas L. Koski, each of whom is a general partner of the partnership or the controlling person of a corporate general partner of the partnership.

F5: Each reporting person disclaims beneficial ownership of all indirectly owned securities in excess of such reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.

F6: Shares owned directly by Thomas L. Koski.

F7: Represents aggregate shares owned by trusts of which Mr. Robert C. Koski is sole trustee. Such trusts are as follows: the Robert Clayton Koski Trust for the benefit of Anthony James Hunter (107,600 shares); the Robert Clayton Koski Trust for the benefit of Hunter Buchanan Koski (107,600 shares); the Robert Clayton Koski Trust for the benefit of Clayton Ward Bennett (100,000 shares); the Robert Clayton Koski Trust for the benefit of Robert Edward Koski (107,600 shares); and the Robert Clayton Koski Trust for the benefit of Elyse Margaux Koski (108,051 shares). Mr. Koski disclaims beneficial ownership of the shares held by the trusts except to the extent of any pecuniary interest.

F8: Shares owned indirectly by Beverly Koski (through Koski Management, Inc).